Wikipedia:Choosing Wisely/American Society of Clinical Oncology

This project shares information from the American Society of Clinical Oncology on Wikipedia.

Articles of interest

Articles relating to American Society of Clinical Oncology content
article	traffic in April 2014*	sources cited	change summary
American Society of Clinical Oncology	1137
Breast cancer	66939		history
Breast cancer treatment	605		history
Cancer	138119		history
Cancer staging	25644		history
Palliative care	61724		history
Prostate cancer	64413		talkpage note.
Chemotherapy	71985
Clinical trial	44417
Febrile neutropenia	5187
Gleason Grading System	14684
Granulocyte colony-stimulating factor	8091
Mammary ductal carcinoma	9062
Management of cancer	4196
Metastasis	56032
Performance status	9183
Positron emission tomography	53451
Prostate cancer staging	4003
Tumor	11708
Tumor marker	11374

• *An arbitrary month has been chosen to present a count of pageviews. This month is neither the busiest nor slowest month, and this number seems typical for most articles in most months. Through the link anyone may check traffic in other months.

Recent changes

Review changes to all of the articles in the above table by visiting this watchlist.

References

American Society of Clinical Oncology (24 April 2014), "Ten Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American Society of Clinical Oncology, retrieved 25 August 2014, which cites

1. • Azzoli, CG; Temin, S; Aliff, T; Baker S, Jr; Brahmer, J; Johnson, DH; Laskin, JL; Masters, G; Milton, D; Nordquist, L; Pao, W; Pfister, DG; Piantadosi, S; Schiller, JH; Smith, R; Smith, TJ; Strawn, JR; Trent, D; Giaccone, G; American Society of Clinical, Oncology (2011 Oct 1). "2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29 (28): 3825–31. PMID 21900105. {{cite journal}}: Check date values in: |date= (help)
   • Ettinger, DS; Akerley, W; Bepler, G; Blum, MG; Chang, A; Cheney, RT; Chirieac, LR; D'Amico, TA; Demmy, TL; Ganti, AK; Govindan, R; Grannis FW, Jr; Jahan, T; Jahanzeb, M; Johnson, DH; Kessinger, A; Komaki, R; Kong, FM; Kris, MG; Krug, LM; Le, QT; Lennes, IT; Martins, R; O'Malley, J; Osarogiagbon, RU; Otterson, GA; Patel, JD; Pisters, KM; Reckamp, K; Riely, GJ; Rohren, E; Simon, GR; Swanson, SJ; Wood, DE; Yang, SC; NCCN Non-Small Cell Lung Cancer Panel, Members (2010 Jul). "Non-small cell lung cancer". Journal of the National Comprehensive Cancer Network : JNCCN. 8 (7): 740–801. PMID 20679538. {{cite journal}}: Check date values in: |date= (help)
   • Carlson, RW; Allred, DC; Anderson, BO; Burstein, HJ; Carter, WB; Edge, SB; Erban, JK; Farrar, WB; Goldstein, LJ; Gradishar, WJ; Hayes, DF; Hudis, CA; Jahanzeb, M; Kiel, K; Ljung, BM; Marcom, PK; Mayer, IA; McCormick, B; Nabell, LM; Pierce, LJ; Reed, EC; Smith, ML; Somlo, G; Theriault, RL; Topham, NS; Ward, JH; Winer, EP; Wolff, AC; NCCN Breast Cancer Clinical Practice Guidelines, Panel (2009 Feb). "Breast cancer. Clinical practice guidelines in oncology". Journal of the National Comprehensive Cancer Network : JNCCN. 7 (2): 122–92. PMID 19200416. {{cite journal}}: Check date values in: |date= (help)
   • Engstrom, PF; Arnoletti, JP; Benson AB, 3rd; Chen, YJ; Choti, MA; Cooper, HS; Covey, A; Dilawari, RA; Early, DS; Enzinger, PC; Fakih, MG; Fleshman J, Jr; Fuchs, C; Grem, JL; Kiel, K; Knol, JA; Leong, LA; Lin, E; Mulcahy, MF; Rao, S; Ryan, DP; Saltz, L; Shibata, D; Skibber, JM; Sofocleous, C; Thomas, J; Venook, AP; Willett, C; National Comprehensive Cancer, Network (2009 Sep). "NCCN Clinical Practice Guidelines in Oncology: colon cancer". Journal of the National Comprehensive Cancer Network : JNCCN. 7 (8): 778–831. PMID 19755046. {{cite journal}}: Check date values in: |date= (help)CS1 maint: numeric names: authors list (link)
   • Smith, Thomas J.; Hillner, Bruce E. (2011). "Bending the Cost Curve in Cancer Care". New England Journal of Medicine. 364 (21): 2060–2065. doi:10.1056/NEJMsb1013826. ISSN 0028-4793.
   • Peppercorn, J. M.; Smith, T. J.; Helft, P. R.; DeBono, D. J.; Berry, S. R.; Wollins, D. S.; Hayes, D. M.; Von Roenn, J. H.; Schnipper, L. E. (2011). "American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer". Journal of Clinical Oncology. 29 (6): 755–760. doi:10.1200/JCO.2010.33.1744. ISSN 0732-183X.
2. • Makarov, DV; Desai, RA; Yu, JB; Sharma, R; Abraham, N; Albertsen, PC; Penson, DF; Gross, CP (2012 Jan). "The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population". The Journal of urology. 187 (1): 97–102. PMID 22088337. {{cite journal}}: Check date values in: |date= (help)
   • National Comprehensive Cancer Network - Prostate (2012). "NCCN Clinical Practice Guidelines in Oncology". nccn.org. Retrieved 15 November 2012.
   • Thompson, I; Thrasher, JB; Aus, G; Burnett, AL; Canby-Hagino, ED; Cookson, MS; D'Amico, AV; Dmochowski, RR; Eton, DT; Forman, JD; Goldenberg, SL; Hernandez, J; Higano, CS; Kraus, SR; Moul, JW; Tangen, CM; AUA Prostate Cancer Clinical Guideline Update, Panel (2007 Jun). "Guideline for the management of clinically localized prostate cancer: 2007 update". The Journal of urology. 177 (6): 2106–31. PMID 17509297. {{cite journal}}: Check date values in: |date= (help)
3. • Carlson, RW; Anderson, BO; Burstein, HJ; Carter, WB; Edge, SB; Farrar, WB; Goldstein, LJ; Gradishar, WJ; Hayes, DF; Hudis, CA; Jahanzeb, M; Ljung, BM; Kiel, K; Marks, LB; McCormick, B; Nabell, LM; Pierce, LJ; Reed, EC; Silver, SM; Smith, ML; Somlo, G; Theriault, RL; Ward, JH; Winer, EP; Wolff, AC (2007 Mar). "Invasive breast cancer". Journal of the National Comprehensive Cancer Network : JNCCN. 5 (3): 246–312. PMID 17439758. {{cite journal}}: Check date values in: |date= (help)
4. • Locker, G. Y.; Hamilton, S.; Harris, J.; Jessup, J. M.; Kemeny, N.; Macdonald, J. S.; Somerfield, M. R.; Hayes, D. F.; Bast, R. C. (2006). "ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer". Journal of Clinical Oncology. 24 (33): 5313–5327. doi:10.1200/JCO.2006.08.2644. ISSN 0732-183X.
   • Desch, CE; Benson AB, 3rd; Somerfield, MR; Flynn, PJ; Krause, C; Loprinzi, CL; Minsky, BD; Pfister, DG; Virgo, KS; Petrelli, NJ; American Society of Clinical, Oncology (2005 Nov 20). "Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline". Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23 (33): 8512–9. PMID 16260687. {{cite journal}}: Check date values in: |date= (help)CS1 maint: numeric names: authors list (link)
   • Carlson, RW; Allred, DC; Anderson, BO; Burstein, HJ; Carter, WB; Edge, SB; Erban, JK; Farrar, WB; Goldstein, LJ; Gradishar, WJ; Hayes, DF; Hudis, CA; Jahanzeb, M; Kiel, K; Ljung, BM; Marcom, PK; Mayer, IA; McCormick, B; Nabell, LM; Pierce, LJ; Reed, EC; Smith, ML; Somlo, G; Theriault, RL; Topham, NS; Ward, JH; Winer, EP; Wolff, AC; NCCN Breast Cancer Clinical Practice Guidelines, Panel (2009 Feb). "Breast cancer. Clinical practice guidelines in oncology". Journal of the National Comprehensive Cancer Network : JNCCN. 7 (2): 122–92. PMID 19200416. {{cite journal}}: Check date values in: |date= (help)
   • Khatcheressian, J. L.; Wolff, A. C.; Smith, T. J.; Grunfeld, E.; Muss, H. B.; Vogel, V. G.; Halberg, F.; Somerfield, M. R.; Davidson, N. E. (2006). "American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting". Journal of Clinical Oncology. 24 (31): 5091–5097. doi:10.1200/JCO.2006.08.8575. ISSN 0732-183X.
   • Harris, L.; Fritsche, H.; Mennel, R.; Norton, L.; Ravdin, P.; Taube, S.; Somerfield, M. R.; Hayes, D. F.; Bast, R. C. (2007). "American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer". Journal of Clinical Oncology. 25 (33): 5287–5312. doi:10.1200/JCO.2007.14.2364. ISSN 0732-183X.
5. • Smith, T. J. (2006). "2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline". Journal of Clinical Oncology. 24 (19): 3187–3205. doi:10.1200/JCO.2006.06.4451. ISSN 0732-183X.
6. • Basch, E.; Prestrud, A. A.; Hesketh, P. J.; Kris, M. G.; Feyer, P. C.; Somerfield, M. R.; Chesney, M.; Clark-Snow, R. A.; Flaherty, A. M.; Freundlich, B.; Morrow, G.; Rao, K. V.; Schwartz,, R. N.; Lyman, G. H. (2011). "Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update". Journal of Clinical Oncology. 29 (31): 4189–4198. doi:10.1200/JCO.2010.34.4614. ISSN 0732-183X.{{cite journal}}: CS1 maint: extra punctuation (link)
   • Saito, Mitsue; Aogi, Kenjiro; Sekine, Ikuo; Yoshizawa, Hirohisa; Yanagita, Yasuhiro; Sakai, Hiroshi; Inoue, Kenichi; Kitagawa, Chiyoe; Ogura, Takashi; Mitsuhashi, Shoichi (2009). "Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial". The Lancet Oncology. 10 (2): 115–124. doi:10.1016/S1470-2045(08)70313-9. ISSN 1470-2045.
   • Aapro, M.; Fabi, A.; Nole, F.; Medici, M.; Steger, G.; Bachmann, C.; Roncoroni, S.; Roila, F. (2010). "Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy". Annals of Oncology. 21 (5): 1083–1088. doi:10.1093/annonc/mdp584. ISSN 0923-7534.
   • Yu, Zhaocai; Liu, Wenchao; Wang, Ling; Liang, Houjie; Huang, Ying; Si, Xiaoming; Zhang, Helong; Liu, Duhu; Zhang, Hongmei (2008). "The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial". Supportive Care in Cancer. 17 (1): 99–102. doi:10.1007/s00520-008-0503-4. ISSN 0941-4355.
7. • Cardoso, F.; Costa, A.; Norton, L.; Cameron, D.; Cufer, T.; Fallowfield, L.; Francis, P.; Gligorov, J.; Kyriakides, S.; Lin, N.; Pagani, O.; Senkus, E.; Thomssen, C.; Aapro, M.; Bergh, J.; Di Leo, A.; El Saghir, N.; Ganz, P.A.; Gelmon, K.; Goldhirsch, A.; Harbeck, N.; Houssami, N.; Hudis, C.; Kaufman, B.; Leadbeater, M.; Mayer, M.; Rodger, A.; Rugo, H.; Sacchini, V.; Sledge, G.; van’t Veer, L.; Viale, G.; Krop, I.; Winer, E. (2012). "1st International consensus guidelines for advanced breast cancer (ABC 1)". The Breast. 21 (3): 242–252. doi:10.1016/j.breast.2012.03.003. ISSN 0960-9776.
   • Carrick, Sue; Parker, Sharon; Thornton, Charlene E; Ghersi, Davina; Simes, John; Wilcken, Nicholas; Carrick, Sue (2009). "Single agent versus combination chemotherapy for metastatic breast cancer". doi:10.1002/14651858.CD003372.pub3. {{cite journal}}: Cite journal requires |journal= (help)
   • Zelenetz, AD; Abramson, JS; Advani, RH; Andreadis, CB; Byrd, JC; Czuczman, MS; Fayad, L; Forero, A; Glenn, MJ; Gockerman, JP; Gordon, LI; Harris, NL; Hoppe, RT; Horwitz, SM; Kaminski, MS; Kim, YH; Lacasce, AS; Mughal, TI; Nademanee, A; Porcu, P; Press, O; Prosnitz, L; Reddy, N; Smith, MR; Sokol, L; Swinnen, L; Vose, JM; Wierda, WG; Yahalom, J; Yunus, F (2010 Mar). "NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas". Journal of the National Comprehensive Cancer Network : JNCCN. 8 (3): 288–334. PMID 20202462. {{cite journal}}: Check date values in: |date= (help)
   • Slamon, Dennis J.; Leyland-Jones, Brian; Shak, Steven; Fuchs, Hank; Paton, Virginia; Bajamonde, Alex; Fleming, Thomas; Eiermann, Wolfgang; Wolter, Janet; Pegram, Mark; Baselga, Jose; Norton, Larry (2001). "Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2". New England Journal of Medicine. 344 (11): 783–792. doi:10.1056/NEJM200103153441101. ISSN 0028-4793.
   • Howell, A. (2002). "Fulvestrant, Formerly ICI 182,780, Is as Effective as Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing After Prior Endocrine Treatment". Journal of Clinical Oncology. 20 (16): 3396–3403. doi:10.1200/JCO.2002.10.057. ISSN 0732-183X.
   • Lutz, Stephen; Berk, Lawrence; Chang, Eric; Chow, Edward; Hahn, Carol; Hoskin, Peter; Howell, David; Konski, Andre; Kachnic, Lisa; Lo, Simon; Sahgal, Arjun; Silverman, Larry; von Gunten, Charles; Mendel, Ehud; Vassil, Andrew; Bruner, Deborah Watkins; Hartsell, William (2011). "Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline". International Journal of Radiation Oncology*Biology*Physics. 79 (4): 965–976. doi:10.1016/j.ijrobp.2010.11.026. ISSN 0360-3016.
8. • Centers for Medicare and Medicaid Services (June 11, 2013). "Decision Memo for Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R4)". cms.gov. Retrieved 3 September 2014.
   • Cancer Care Ontario (May 28, 2012). "PET Imaging in Ontario - CCO". cancercare.on.ca. Retrieved 3 September 2014.
   • Labianca, R.; Nordlinger, B.; Beretta, G. D.; Brouquet, A.; Cervantes, A. (2010). "Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up". Annals of Oncology. 21 (Supplement 5): v70 – v77. doi:10.1093/annonc/mdq168. ISSN 0923-7534.
9. • Raghavan, Derek (2013). "PSA: Please Stop Agonizing (Over Prostate-Specific Antigen Interpretation)". Mayo Clinic Proceedings. 88 (1): 1–3. doi:10.1016/j.mayocp.2012.11.004. ISSN 0025-6196.
   • Schröder, Fritz H.; Hugosson, Jonas; Roobol, Monique J.; Tammela, Teuvo L.J.; Ciatto, Stefano; Nelen, Vera; Kwiatkowski, Maciej; Lujan, Marcos; Lilja, Hans; Zappa, Marco; Denis, Louis J.; Recker, Franz; Páez, Alvaro; Määttänen, Liisa; Bangma, Chris H.; Aus, Gunnar; Carlsson, Sigrid; Villers, Arnauld; Rebillard, Xavier; van der Kwast, Theodorus; Kujala, Paula M.; Blijenberg, Bert G.; Stenman, Ulf-Hakan; Huber, Andreas; Taari, Kimmo; Hakama, Matti; Moss, Sue M.; de Koning, Harry J.; Auvinen, Anssi (2012). "Prostate-Cancer Mortality at 11 Years of Follow-up". New England Journal of Medicine. 366 (11): 981–990. doi:10.1056/NEJMoa1113135. ISSN 0028-4793.
   • Hugosson, Jonas; Carlsson, Sigrid; Aus, Gunnar; Bergdahl, Svante; Khatami, Ali; Lodding, Pär; Pihl, Carl-Gustaf; Stranne, Johan; Holmberg, Erik; Lilja, Hans (2010). "Mortality results from the Göteborg randomised population-based prostate-cancer screening trial". The Lancet Oncology. 11 (8): 725–732. doi:10.1016/S1470-2045(10)70146-7. ISSN 1470-2045.
   • Andriole, Gerald L.; Crawford, E. David; Grubb, Robert L.; Buys, Saundra S.; Chia, David; Church, Timothy R.; Fouad, Mona N.; Gelmann, Edward P.; Kvale, Paul A.; Reding, Douglas J.; Weissfeld, Joel L.; Yokochi, Lance A.; O'Brien, Barbara; Clapp, Jonathan D.; Rathmell, Joshua M.; Riley, Thomas L.; Hayes, Richard B.; Kramer, Barnett S.; Izmirlian, Grant; Miller, Anthony B.; Pinsky, Paul F.; Prorok, Philip C.; Gohagan, John K.; Berg, Christine D. (2009). "Mortality Results from a Randomized Prostate-Cancer Screening Trial". New England Journal of Medicine. 360 (13): 1310–1319. doi:10.1056/NEJMoa0810696. ISSN 0028-4793.
   • Moyer, Virginia A. (2012). "Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine. 157 (2): 120. doi:10.7326/0003-4819-157-2-201207170-00459. ISSN 0003-4819.
   • Qaseem, Amir (2013). "Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians". Annals of Internal Medicine. 158 (10): 761. doi:10.7326/0003-4819-158-10-201305210-00633. ISSN 0003-4819.
   • Qaseem, Amir (2013). "Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians". Annals of Internal Medicine. 158 (10): 761. doi:10.7326/0003-4819-158-10-201305210-00633. ISSN 0003-4819.
   • Basch, E.; Oliver, T. K.; Vickers, A.; Thompson, I.; Kantoff, P.; Parnes, H.; Loblaw, D. A.; Roth, B.; Williams, J.; Nam, R. K. (2012). "Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion". Journal of Clinical Oncology. 30 (24): 3020–3025. doi:10.1200/JCO.2012.43.3441. ISSN 0732-183X.
10. • Shaw, Alice T.; Kim, Dong-Wan; Nakagawa, Kazuhiko; Seto, Takashi; Crinó, Lucio; Ahn, Myung-Ju; De Pas, Tommaso; Besse, Benjamin; Solomon, Benjamin J.; Blackhall, Fiona; Wu, Yi-Long; Thomas, Michael; O'Byrne, Kenneth J.; Moro-Sibilot, Denis; Camidge, D. Ross; Mok, Tony; Hirsh, Vera; Riely, Gregory J.; Iyer, Shrividya; Tassell, Vanessa; Polli, Anna; Wilner, Keith D.; Jänne, Pasi A. (2013). "Crizotinib versus Chemotherapy in AdvancedALK-Positive Lung Cancer". New England Journal of Medicine. 368 (25): 2385–2394. doi:10.1056/NEJMoa1214886. ISSN 0028-4793.
    • Sequist, L. V.; Yang, J. C.-H.; Yamamoto, N.; O'Byrne, K.; Hirsh, V.; Mok, T.; Geater, S. L.; Orlov, S.; Tsai, C.-M.; Boyer, M.; Su, W.-C.; Bennouna, J.; Kato, T.; Gorbunova, V.; Lee, K. H.; Shah, R.; Massey, D.; Zazulina, V.; Shahidi, M.; Schuler, M. (2013). "Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations". Journal of Clinical Oncology. 31 (27): 3327–3334. doi:10.1200/JCO.2012.44.2806. ISSN 0732-183X.
    • Chapman, Paul B.; Hauschild, Axel; Robert, Caroline; Haanen, John B.; Ascierto, Paolo; Larkin, James; Dummer, Reinhard; Garbe, Claus; Testori, Alessandro; Maio, Michele; Hogg, David; Lorigan, Paul; Lebbe, Celeste; Jouary, Thomas; Schadendorf, Dirk; Ribas, Antoni; O'Day, Steven J.; Sosman, Jeffrey A.; Kirkwood, John M.; Eggermont, Alexander M.M.; Dreno, Brigitte; Nolop, Keith; Li, Jiang; Nelson, Betty; Hou, Jeannie; Lee, Richard J.; Flaherty, Keith T.; McArthur, Grant A. (2011). "Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation". New England Journal of Medicine. 364 (26): 2507–2516. doi:10.1056/NEJMoa1103782. ISSN 0028-4793.
    • Lynch, Thomas J.; Bell, Daphne W.; Sordella, Raffaella; Gurubhagavatula, Sarada; Okimoto, Ross A.; Brannigan, Brian W.; Harris, Patricia L.; Haserlat, Sara M.; Supko, Jeffrey G.; Haluska, Frank G.; Louis, David N.; Christiani, David C.; Settleman, Jeff; Haber, Daniel A. (2004). "Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib". New England Journal of Medicine. 350 (21): 2129–2139. doi:10.1056/NEJMoa040938. ISSN 0028-4793.
    • Keedy, V. L.; Temin, S.; Somerfield, M. R.; Beasley, M. B.; Johnson, D. H.; McShane, L. M.; Milton, D. T.; Strawn, J. R.; Wakelee, H. A.; Giaccone, G. (2011). "American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy". Journal of Clinical Oncology. 29 (15): 2121–2127. doi:10.1200/JCO.2010.31.8923. ISSN 0732-183X.
    • Allegra, C. J.; Jessup, J. M.; Somerfield, M. R.; Hamilton, S. R.; Hammond, E. H.; Hayes, D. F.; McAllister, P. K.; Morton, R. F.; Schilsky, R. L. (2009). "American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy". Journal of Clinical Oncology. 27 (12): 2091–2096. doi:10.1200/JCO.2009.21.9170. ISSN 0732-183X.

Links

• American Society of Clinical Oncology